Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Acute myocarditis (AM) is an inflammatory cardiac condition resulting from infections, toxic exposures, or immune-mediated mechanisms, with clinical presentations ranging from mild symptoms to heart failure (HF) or cardiogenic shock. Although viral infections remain the predominant cause, both the absolute prevalence and the relative distribution of different etiologies may change over time and across regions depending on endemic diseases. Immune checkpoint inhibitor (ICI)-associated myocarditis has emerged as a newly recognized entity, with diagnostic rates increasing in parallel with growing awareness and the expanding population of cancer patients eligible for ICI therapy. Additionally, genetic predisposition—particularly mutations linked to arrhythmogenic cardiomyopathy—is also being increasingly acknowledged as a susceptibility factor. Recent advances have markedly improved the diagnostic approach to AM. The availability of high-sensitivity cardiac troponins and the widespread use of cardiac magnetic resonance imaging (CMRI) have enhanced early detection and tissue characterization. CMRI, especially following the updated Lake Louise Criteria (2018), which incorporate T1 and T2 mapping, enables accurate assessment of myocardial inflammation and fibrosis. Endomyocardial biopsy (EMB) remains essential in complicated cases, particularly to identify histologic subtypes that may benefit from immunosuppressive therapy. Early EMB (within 48 h) has been associated with better outcomes in fulminant presentations. The use of immunohistochemistry with leukocyte-specific markers has further increased the sensitivity of EMB. Therapeutic strategies now integrate etiology-specific approaches. Immunosuppressive therapy is indicated for distinct histological forms such as eosinophilic (EM) and giant cell myocarditis (GCM) or cases associated with systemic autoimmune disease. Conversely, in most patients with acute myocarditis complicated by acute HF or cardiogenic shock, no specific treatment is currently recommended beyond evidence-based management of acute HF and general supportive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Cardiac magnetic resonance findings. Acute non-ischaemic myocardial injury at mid to apical septal, anterior, and anterolateral walls. (A) Increased native T1 values (up to 1260 ms); (B) increased T2 values (up to 71 ms); (C) increased signal intensity at T2-weighted images; and (D) nonischaemic late gadolinium enhancement. All abnormal findings have matched subepicardial distribution (white arrows). Reproduced with permission from ref. [81].](https://figures.cochat.ai/paper-figures/dbef605113164504a25dbc2c57712e5c/evolution-in-the-diagnosis-and-treatment-of-myocarditis-in-recent-years-state-of-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, human myocarditis is aetiologically heterogeneous, encompassing viral, autoimmune, and immune checkpoint inhibitor-associated forms, each potentially engaging distinct macrophage programmes [2].”
From Cardiac Macrophages Exhibit Dynamic Heterogeneity and Functional Specialization During Experimental Autoimmune Myocarditis. (2026) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad195 · Cited by 2,612
2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217
Cited by
Monocyte Titin Gene Expression as a Biomarker of Left Ventricular Dysfunction in Acute Myocarditis
Maragkoudakis, S., Sallo, A., Kontaraki, I., Sideras, E. M., Lilikaki, G., Malikides, O., Fragkiadakis, K., Kallergis, E. M., Kopidakis, N., Kopidakis, I., et al. (2026) · Genes · doi:10.3390/genes17030268 · Cited by 1
“Although high-sensitivity troponins (hs-cTn) and advances in cardiovascular imaging have improved diagnosis, critical gaps persist in forecasting clinical trajectories, tailoring therapeutic interventions, and deciphering underlying patho-physiological mechanisms [4].”
Stefanska, M., Kot, M., Koterba, D., & Zeyland, J. (2026) · Cells · doi:10.3390/cells15121110
“The etiology of the disease is diverse and includes both infectious agents (e.g., viruses such as Coxsackievirus ) and non-infectious factors (e.g., autoimmune processes) [2–4].”
InfluentialCriteria for safe return to sports activity after myocarditis: An analysis of clinical practice
Gólcz, J., Bursztyn, M., Szaryński, M., Sikorski, A., Kadłubowska, K., Jakubowska, P., Chojnowska, N., Rytel, J., Jakubowska, M., Gólcz, A., et al. (2026) · Quality in Sport · doi:10.12775/qs.2026.49.67509
Multimodality Imaging in Myocarditis: Integrating Etiology, Diagnosis, and Risk Stratification
Cheikh-Debs, D., Rushworth, P., Liu, J., Lee, C., Moslehi, J. J., & Salerno, M. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02374-4
“Functional impairment can be assessed via multiple imaging modalities including echocardiography, CMR, CCT, and nuclear imaging [ 4 ].”
Lucki, M., Lucka, E., Grygiel‐Górniak, B., Iwańczyk, S., Mitkowski, P. P., & Lesiak, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125513
“The expanding availability of targeted biologic and small-molecule therapies in rheumatology creates new opportunities for mechanism-based treatment of autoimmune myocardial disease, provided that myocardial phenotyping becomes sufficiently precise [5,14,15,18,41,52].”
Metadata
- Authors
- Campodonico, J., Lauri, C., Pezzuto, B., Agostoni, P., & Vignati, C.
- Affiliations
- Centro Cardiologico Monzino (IT)
- University of Insubria (IT)
- University of Milan (IT)
- Corresponding author
- Vignati, Carlo
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2025-10-28
- Volume
- 14
- Issue
- 21
- Pages
- 7661
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC12608363
- OpenAlex
- W4415683551
- Cited by
- 6
- References
- 107
- Citations by year
- 2026: 6
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Takotsubo Cardiomyopathy and Associated Phenomena
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- acute myocarditis, immune checkpoint inhibitor-associated myocarditis, viral myocarditis, arrhythmogenic cardiomyopathy, endomyocardial biopsy, cardiac magnetic resonance imaging, Lake Louise criteria, high-sensitivity troponin, immunosuppressive therapy, eosinophilic myocarditis, giant cell myocarditis, heart failure, cardiogenic shock
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art. https://app.cochat.ai/papers/10.3390/jcm14217661
- The paper
- Campodonico, J., Lauri, C., Pezzuto, B., Agostoni, P., & Vignati, C. (2025). Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14217661
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.